Ontology highlight
ABSTRACT:
SUBMITTER: Palubeckaite I
PROVIDER: S-EPMC9928768 | biostudies-literature | 2023 Mar
REPOSITORIES: biostudies-literature
Palubeckaitė Ieva I Venneker Sanne S van den Akker Brendy E W M BEWM Briaire-de Bruijn Inge H IH Boveé Judith V M G JVMG
Clinical orthopaedics and related research 20221213 3
<h4>Background</h4>Chondrosarcomas are well known for their resistance to conventional chemotherapy and radiotherapy treatment regimens, which is particularly detrimental in patients who have unresectable tumors. Recently, inhibition of poly(ADP-ribose) polymerase (PARP) by talazoparib was shown to sensitize chondrosarcoma cell lines to chemotherapy (temozolomide) or radiotherapy, irrespective of isocitrate dehydrogenase (IDH) mutation status. Because two-dimensionally grown cell lines have limi ...[more]